Structure elucidation and identification of a common metabolite for naphthoylindole-based synthetic cannabinoids using LC-TOF and comparison to a synthetic reference standard

Forensic Science International

Volumn 226, Issue 1-3, 2013, Pages 81-87

  Lovett, Dennis P ^a   Yanes, Enrique G ^a   Herbelin, Travis W ^a   Knoerzer, Timm A ^b   Levisky, Joseph A ^b  

^a Lackland Air Force Base ^*  (United States)

^b UNITED STATES AIR FORCE ACADEMY   (United States)

Author keywords

Common biomarker; JWH 072 metabolite; LC TOF; NMR; Synthetic cannabinoid metabolites; UPLC

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 3 [3 [1-NAPHTHOYL] 1H INDOL 1 YL] PROPANOIC ACID; BIOLOGICAL MARKER; CANNABINOID; DRUG METABOLITE; JWH 018 METHYL ESTER; JWH 018 N (4 HYDROXYPENTYL); JWH 018 N (5 HYDROXYPENTYL); JWH 018 N PENTANOIC ACID; JWH 072; JWH 073; JWH 073 N (3 HYDROXYBUTYL); JWH 073 N BUTANOIC ACID; NAPHTHOYLINDOLE SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DERIVATIZATION; DRUG IDENTIFICATION; DRUG STRUCTURE; LABORATORY TEST; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS;

EID: 84875632761     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.12.012     Document Type: Article

References (9)

1. Mustata C., Torrens M., Pardo R., Perez C. The Psychonaut web mapping group, M. Farre, spice drugs: cannabinoids as a new designer drugs. Adicciones 2009, 21:181.
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Thematic Paper-understanding the 'Spice' Phenomenon 2009, Luxembourg, p. 3.
3. Atwood B.K., Huffman J.W., Straiker A., Mackie K. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB1 agonist. Br. J. Pharmacol. 2010, 1.
4. Food and Drug Administration Safety and Innovation Act, (accessed 07.09.12). http://www.gpo.gov/fdsys/pkg/BILLS-112s3187enr/pdf/BILLS-112s3187enr.pdf.
5. Sacco L.N., Finklea K.M. Synthetic drugs: overview and issues for congress. Congressional Research Service (CRS) Report for Congress 2011.
6. Yanes E.G., Lovett D.P. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS. J. Chromatogr. B 2012, 909:42-50.
7. Moran C.L., Huyen Le V.-H., Chimalakonda K.C., Smedley A.L., Lackey F.D., Owen S.N., Kennedy P.D., Endres G.W., Ciske F.L., Kramer J.B., Kornilov A.M., Bratton L.D., Dobrowolski P.J., Wessinger W.D., Fantegrossi W.E., Prather P.L., James L.P., Radominska-Pandya A., Moran J.H. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal. Chem. 2011, 83:4228-4236.
8. Chimalakonda K.C., Moran C.L., Kennedy P.D., Endres G.W., Uzieblo A., Dobrowolski P.J., Fifer E.K., Lapoint J., Nelson L.S., Hoffman R.S., James L.P., Radominska-Pandya A., Moran J.H. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal. Chem. 2011, 83:6381-6388.
9. B.R. Martin, J.W. Huffman, US Patent Application 2005/0009903 A1.